btgbtg/iStock via Getty Images In only two more weeks, Switzerland will hold a referendum that could completely reshape its economy. Citizens will decide on whether to cap the country's population at 10M due to concerns about overcrowding and rising anti-immigrant sentiment across Europe. It's a big deal, since Switzerland already has over 9.1M residents, meaning current immigration would need to ...
btgbtg/iStock via Getty Images In only two more weeks, Switzerland will hold a referendum that could completely reshape its economy. Citizens will decide on whether to cap the country's population at 10M due to concerns about overcrowding and rising anti-immigrant sentiment across Europe. It's a big deal, since Switzerland already has over 9.1M residents, meaning current immigration would need to be halved in the coming decades. For or against: The "No to ten million" immigration initiative was launched by the Swiss People's Party, though support currently appears to be split across the population. Backers of the measure say Switzerland has reached capacity, with strained infrastructure and housing, congested roads and trains, as well as the social security system. Those who oppose the measure argue that the country has absorbed immigration well, which has led to integration, growth and the nation's success. Many business executives are alarmed, as the initiative would also bar highly skilled workers from being employed in the country (not just asylum seekers or refugees). Case in point: In Zurich, Alphabet ( GOOGL ) employs over 5,000 foreign workers from 85 countries, while notable drugmaker Roche ( RHHBY ) employs thousands of workers at its Basel/Kaiseraugst campus from more than 100 countries. "Switzerland cannot meet the need for bright minds on its own," Roche ( RHHBY ) Chairman Severin Schwan declared earlier this year. "It's vital to keep the borders open for top talent." EU danger: A hard cap on the total permanent resident population, whether citizen or foreigner, contradicts the fundamental principle of free movement within the European Single Market. That could lead to a rupture with the EU, which is Switzerland's largest trading partner and biggest export destination. It wouldn't be easy to jeopardize access to the $23T economy and its 450M consumers, and might lead to renegotiated or terminated bilateral agreements. Seeking Alpha survey: As the Swiss ...
BlackJack3D/E+ via Getty Images Taysha Gene Therapies, Inc. ( TSHA ) is a pre-revenue biotech company that scrapped its main pipeline in 2023 due to FDA approval hurdles. Up to that point, they were focusing on a pipeline that consisted of 20 different gene therapies, specifically the lead asset TSHA-120 for Giant Axonal Neuropathy (GAN). Taysha, unlike many other companies that scrap their pipeli...
BlackJack3D/E+ via Getty Images Taysha Gene Therapies, Inc. ( TSHA ) is a pre-revenue biotech company that scrapped its main pipeline in 2023 due to FDA approval hurdles. Up to that point, they were focusing on a pipeline that consisted of 20 different gene therapies, specifically the lead asset TSHA-120 for Giant Axonal Neuropathy (GAN). Taysha, unlike many other companies that scrap their pipeline because the drug in question fails, was already scaling back to save cash when the FDA demanded financially undoable trials for TSHA-120. As a response to this, their partner walked away , which left the company without cash to pay for the demanded trials. Management made the decision to pull the plug on the whole pipeline of about 20 drugs and became a one-drug company, which allowed them to reduce their forward spending, but also made them more vulnerable. At this point, Taysha is fully reliant on the success of their new flagship asset, TSHA-102. I currently rate the company as a BUY, because they do have very good cash reserves, and their results so far have looked very promising. Based on this, the FDA has recently allowed the asset to essentially skip the Phase 3 trial which shaved off about 3 years of the timeline that leads towards commercialization. On the other hand Taysha does have competition in this new field they have entered, and considering that the market for Rett syndrome (TSHA-102) across the world is quite small (in the thousands), if this competition proves to have a better therapy, TSHA-102 might face issues. However, my bull rating is also supported by the company's fair, risk adjusted price. Therefore, I believe that buying before the final pivotal data results is fairly de-risked and might prove to be a good bet for the long term. Main Pipeline Drug The main pipeline drug of Taysha (TSHA-102) focuses on treating Rett syndrome, which is a neurodevelopmental disorder that affects mostly females, with currently no FDA-approved therapeutics in the US...
In this article .SPX Follow your favorite stocks CREATE FREE ACCOUNT (L to R) Jensen Huang, President and CEO of Nvidia Corporation, Google CEO Sundar Pichai and Mark Zuckerberg, CEO of Meta, arrive for a U.S. Senate bipartisan Artificial Intelligence Insight Forum at the US Capitol in Washington, D.C., on Sept. 13, 2023. Andrew Caballero-reynolds | Afp | Getty Images Seemingly every company is ob...
In this article .SPX Follow your favorite stocks CREATE FREE ACCOUNT (L to R) Jensen Huang, President and CEO of Nvidia Corporation, Google CEO Sundar Pichai and Mark Zuckerberg, CEO of Meta, arrive for a U.S. Senate bipartisan Artificial Intelligence Insight Forum at the US Capitol in Washington, D.C., on Sept. 13, 2023. Andrew Caballero-reynolds | Afp | Getty Images Seemingly every company is obsessed with artificial intelligence these days, whether it's how the technology is transforming their industry or the effects it's having on employees and customers. But the degree to which companies are utilizing AI tools internally and adapting to a rapidly changing reality varies dramatically. A new study from AI-Driven Enterprise Institute (AIDE) breaks down how well S&P 500 companies — and their leaders — are adopting AI compared to their peers. The top performers, unsurprisingly, are centered in the tech industry, according to the data, which was shared with CNBC. In looking at four areas — literacy, advocacy, orientation and implementation — AIDE gave each company a score of up to 100 in the four categories and then provided an overall index score. In technology, the highest company score (the average of the orientation and implementation pillars) and the only 100, went to chipmaker Nvidia , which has become the world's largest company by selling the chips and systems that have powered the development of AI models and services. Meta and Amazon also scored 100, but in the S&P 500, those companies are considered communication services and consumer discretionary names, respectively. Read more CNBC tech news SpaceX skeptics have added reason for concern after Musk comments diverge from IPO filing Infighting, court battles could put long-hyped air taxi breakthrough in jeopardy Blue Origin rocket explodes on launchpad during ground test Nvidia is investing billions into an emerging technology that could change the AI industry The only other 100 company score went to energy...
Millions Of Americans Are Giving Up On Buying New Cars A growing number of Americans can no longer afford to buy new vehicles. Since 2020, roughly one million potential buyers have exited the market, and industry forecasts suggest they are unlikely to return soon, according to Wall Street Journal . Although automakers initially expected sales to recover to pre-pandemic levels, persistent economic ...
Millions Of Americans Are Giving Up On Buying New Cars A growing number of Americans can no longer afford to buy new vehicles. Since 2020, roughly one million potential buyers have exited the market, and industry forecasts suggest they are unlikely to return soon, according to Wall Street Journal . Although automakers initially expected sales to recover to pre-pandemic levels, persistent economic pressures have kept demand below earlier expectations. Before COVID-19, U.S. new-vehicle sales typically reached around 17 million units annually. Today, most forecasts place demand closer to 16 million vehicles or less, with little chance of a full recovery in the near future. One major reason is cost: the average new vehicle now sells for nearly $50,000, and many models exceed $55,000. As entry-level options disappear, new cars have become increasingly out of reach for middle-income households. The WSJ writes that automakers recognize that affordability has become a major obstacle. While some companies have announced plans to introduce less expensive models, substantial price reductions are not expected anytime soon. Rather than competing through discounts, manufacturers have concentrated on producing higher-margin vehicles such as pickups, SUVs, and premium trims. The industry's approach changed during the pandemic, when supply shortages limited production but allowed companies to maintain strong profits through higher prices. That experience convinced many automakers that selling fewer vehicles can be more profitable than chasing volume through aggressive incentives. As a result, manufacturers have become more cautious about discounting and more focused on protecting profit margins. Consumers who are priced out of the new-car market often look to used vehicles instead, but prices there have also risen significantly. Many households have responded by delaying purchases altogether and keeping their current vehicles longer. This trend has pushed the average age of cars and...
Guido Mieth/DigitalVision via Getty Images Commentary as of 03/31/26 The fund posted returns of 20.39% (Institutional shares) and 20.31% (Investor A shares, without sales charge) for the first quarter of 2026. The fund's underperformance of its benchmark was largely due to weakness in natural resource equities, which offset positive energy commodity exposure. At quarter-end, the fund had an overwe...
Guido Mieth/DigitalVision via Getty Images Commentary as of 03/31/26 The fund posted returns of 20.39% (Institutional shares) and 20.31% (Investor A shares, without sales charge) for the first quarter of 2026. The fund's underperformance of its benchmark was largely due to weakness in natural resource equities, which offset positive energy commodity exposure. At quarter-end, the fund had an overweight position in the precious metals sector and slightly underweight holdings in the agriculture, industrial metals, and energy sectors. Contributors Detractors Energy commodity exposure was the largest contributor to absolute returns, though all commodity positions benefited performance. Within the equity allocation, positions in integrated oil and gas companies ExxonMobil ( XOM ), Chevron ( CVX ), and Shell ( SHEL ) were among the best performers as the Iran-related supply shock boosted energy prices. The holding in Corteva ( CTVA ) was a positive contributor, underpinned by solid execution and its defensive earnings profile. Natural resource equities generally lagged the benchmark due to short-term supply disruptions. At the stock level, Novozymes ( NVZMF ) weighed on returns given weaker-than-expected earnings and currency headwinds, while Northern Star Resources ( NESRF ) and Ivanhoe Mines ( IVPAF ) were pressured by operational challenges at key assets. Zijin Mining ( ZIJMF ) was challenged amid valuation concerns and profit-taking, despite broadly supportive commodity fundamentals. Click to enlarge Further insight We view commodity and natural resource equities as an increasingly attractive diversifier in the current geopolitical environment. While structural demand for materials continues to be driven by electrification, grid investment, and renewable development, the Iran conflict has materially raised geopolitical risk premiums across energy, metals, and precious metals. This has heightened the risk of supply disruptions in already tight markets following years of...
Robert Way/iStock Editorial via Getty Images Li Auto ( LI ) delivered 33,350 vehicles in May 2026, down ~18.4% from 40,856 deliveries a year earlier and slightly below the 34,085 vehicles delivered in April 2026. As of May 31, 2026, the company's cumulative deliveries totaled 1,702,792 vehicles. Since March this year, monthly deliveries of Li i6 have consistently exceeded 20,000 units, the company...
Robert Way/iStock Editorial via Getty Images Li Auto ( LI ) delivered 33,350 vehicles in May 2026, down ~18.4% from 40,856 deliveries a year earlier and slightly below the 34,085 vehicles delivered in April 2026. As of May 31, 2026, the company's cumulative deliveries totaled 1,702,792 vehicles. Since March this year, monthly deliveries of Li i6 have consistently exceeded 20,000 units, the company said. In May, Li Auto ( LI ) launched and commenced deliveries of the all-new Li L9, initiating a fresh product update cycle for the Li L series. Within two weeks of its launch, the all-new Li L9 Livis received over 10,000 orders. In comparison, NIO ( NIO ) said it delivered 37,705 vehicles in May 2026, marking a 62.3% increase year-over-year (Y/Y) and a 28.4% surge month-over-month (M/M) from the 29,356 vehicles delivered in April. XPeng ( XPEV ) delivered 32,158 vehicles in May, representing a 4% increase from the prior month. More on Li Auto Li Auto: Margin Plunge (Rating Downgrade) Li Auto Inc. (LI) Q1 2026 Earnings Call Transcript Li Auto: Should We Be Skeptical Amid Broader Sector Recovery? Li Auto expects Q2 2026 deliveries of 95,000 to 100,000 as it targets over 20% share in RMB 500,000+ NEV SUVs Li Auto Non-GAAP EPADS of -$0.30 in-line, revenue of $3.3B beats by $110M; gives Q2 outlook
Macau gross gaming revenue increased 6.7% year over year in May to 22.6B patacas ($2.80B), according to data from the Gaming Inspection and Coordination Bureau. The GGR tally was in line with analyst expectations and up 13% on a sequential basis from the level seen in April. The month benefited from solid demand during the Labor Day holiday that leaked into May. For the first five months of 2026, ...
Macau gross gaming revenue increased 6.7% year over year in May to 22.6B patacas ($2.80B), according to data from the Gaming Inspection and Coordination Bureau. The GGR tally was in line with analyst expectations and up 13% on a sequential basis from the level seen in April. The month benefited from solid demand during the Labor Day holiday that leaked into May. For the first five months of 2026, Macau GGR is up 10.9% year over year to 108.4B patacas ($13.4B). Looking ahead, analysts have noted that the monthly comparisons will become more difficult. Jefferies analyst Anne Ling highlighted that the challenging comparisons drive the firm's measured enthusiasm. Against the tougher backdrop, Wynn Resorts ( WYNN ) and Galaxy Entertainment (GZYEF) are expected to continue to take market share in the premium mass segment while others remain stable or struggle competitively. Macau casino stocks : Wynn Macau ( WYNMF ) ( WYNMY ), Wynn Resorts ( WYNN ), Sands China ( SCHYY ) ( SCHYF ), Las Vegas Sands ( LVS ), and MGM China ( MCHVF ) ( MCHVY ). MGM Resorts ( MGM ), Galaxy Entertainment ( GXYEF ), SJM Holdings ( SJMHF ) ( SJMHY ), Melco Resorts & Entertainment ( MLCO ), and Studio City International ( MSC ). More on the Macau casino sector Melco Resorts: Q1 2026 Earnings Confirms Our Bullish Case Melco Resorts & Entertainment Limited 2026 Q1 - Results - Earnings Call Presentation Melco Resorts & Entertainment Limited (MLCO) Q1 2026 Earnings Call Transcript Texas Capital sees upside for Melco Resorts & Entertainment Macau gaming revenue rises 5.5% in April, still up double digits for the year
Abelardo de la Espriella dio la sorpresa en la primera vuelta presidencial de Colombia al obtener el 44% de los votos. El abogado conservador enfrentará al senador de izquierda Iván Cepeda en la segunda vuelta del 21 de junio. (Source: Bloomberg)
Abelardo de la Espriella dio la sorpresa en la primera vuelta presidencial de Colombia al obtener el 44% de los votos. El abogado conservador enfrentará al senador de izquierda Iván Cepeda en la segunda vuelta del 21 de junio. (Source: Bloomberg)
The outbreak remains focused in Congo's eastern Ituri province. Congo has reported over 1,000 suspected cases with the Bundibugyo virus, which has no approved treatment or vaccine. (Image credit: Moses Sawasawa)
The outbreak remains focused in Congo's eastern Ituri province. Congo has reported over 1,000 suspected cases with the Bundibugyo virus, which has no approved treatment or vaccine. (Image credit: Moses Sawasawa)
Constellation Energy ( CEG ) has announced an underwritten secondary public offering of 11M common shares by certain existing shareholders. The company will not receive any proceeds from any sale of shares by the selling shareholders. The company intends to repurchase 2M common shares from the underwriters at the price paid to the selling shareholders by the underwriters in the offering. The under...
Constellation Energy ( CEG ) has announced an underwritten secondary public offering of 11M common shares by certain existing shareholders. The company will not receive any proceeds from any sale of shares by the selling shareholders. The company intends to repurchase 2M common shares from the underwriters at the price paid to the selling shareholders by the underwriters in the offering. The underwriters have a 30-day option to purchase up to an additional 1.35M common shares from the selling shareholders. Press Release More on Constellation Energy If You Still Think Constellation Energy Is A Utility Stock, It's Time To Update Your Perspective Constellation Energy: Buy The Pullback Before Data Center Deals Arrive The AI Power Bottleneck Makes Constellation Energy A Strong Buy DoE directs Constellation Energy to delay closure of two units at Eddystone power plant Utility shares surge on PJM's plans to speed up data center timeline
Jonathan Kitchen Seeking Alpha's Quant Rating system has identified a group of sub-$10 stocks that score near the very top of its quantitative rankings, a rare distinction given that penny and micro-cap stocks often struggle to meet the profitability, growth, and momentum thresholds that drive high quant scores. All 10 names on this list carry Strong Buy ratings above 4.90, placing them among the ...
Jonathan Kitchen Seeking Alpha's Quant Rating system has identified a group of sub-$10 stocks that score near the very top of its quantitative rankings, a rare distinction given that penny and micro-cap stocks often struggle to meet the profitability, growth, and momentum thresholds that drive high quant scores. All 10 names on this list carry Strong Buy ratings above 4.90, placing them among the highest-rated stocks in the entire Seeking Alpha universe regardless of price, a signal that the quantitative case for these names is unusually compelling relative to their peers. Rackspace Technology ( RXT ) and Alto Ingredients ( ALTO ) lead the list, each with a Quant Rating of 4.98. Netlist, Inc. ( NLST ) and Commercial Vehicle Group, Inc. ( CVGI ) follow closely behind, both posting scores of 4.97. Tilly’s, Inc. ( TLYS ) rounds out the top five with a rating of 4.96. Other notable names on the list include BlackBerry Limited ( BB ), with a Quant Rating of 4.93, and Digital Turbine, Inc. ( APPS ), which closes out the top 10 with a score of 4.90. Here is the list: Rackspace Technology, Inc. ( RXT ), Quant Rating: 4.98 Alto Ingredients, Inc. ( ALTO ), Quant Rating: 4.98 Netlist, Inc. ( NLST ), Quant Rating: 4.97 Commercial Vehicle Group, Inc. ( CVGI ), Quant Rating: 4.97 Tilly’s, Inc. ( TLYS ), Quant Rating: 4.96 Equillium, Inc. ( EQ ), Quant Rating: 4.94 Lifetime Brands, Inc. ( LCUT ), Quant Rating: 4.94 BlackBerry Limited ( BB ), Quant Rating: 4.93 Imperial Petroleum Inc. ( IMPP ), Quant Rating: 4.91 Digital Turbine, Inc. ( APPS ), Quant Rating: 4.90 More on Rackspace Technology, Alto Ingredients, etc. BlackBerry: Has The Potential To Become The Operating System For Physical AI Digital Turbine: Don't Look Under The Hood (Rating Downgrade) Digital Turbine, Inc. (APPS) Q4 2026 Earnings Call Prepared Remarks Transcript Quant snapshot: Ciena, Tilly’s among top-rated names as Here Group, Oddity Tech lag Digital Turbine soars on back of BofA upgrade